Gene-modified Cell Treatments Market Size, Share, and Industry Analysis, By Therapy Type (Chimeric Antigen Receptor T-cell therapy, T-cell Receptor T-cell Therapies, Chimeric Antigen Receptor-Natural Killer Cell Therapy, and Others), By Disease Indication (Oncology, Hematology, Autoimmune Disorders, Rare Diseases, and Others), By End User (Hospitals & Specialty Clinics, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies), and Regional Forecast, 2026-2034